Brazil's BRF launches chilled chicken line in Saudi Arabia
The launch marks yet another push by BRF to strengthen its presence in Saudi Arabia, reducing dependence on export sales to the kingdom by increasing domestic supplies in a key market for the company.
Demand for chilled chicken in Saudi Arabia in 2024 was more than 300,000 metric tons, the statement said. BRF estimates Saudi Arabia's chilled chicken market to grow between 2.5% and 3.5% per year through 2030, citing data from market researcher Mordor Intelligence.
BRF, whose flagship Sadia brand is a market leader in 14 countries of the Middle East, operates a factory in the Saudi town of Dammam and is building another in Jeddah to process meat products.
(Reporting by Ana Mano; Editing by Aurora Ellis)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
20 minutes ago
- Zawya
Saudi: Alkhabeer Capital joins AWRAAQ Digital to launch Block Trade Negotiation System
Riyadh – Alkhabeer Capital, a financial institution specializing in Sharia-compliant financial services and brokerage services, has collaborated with AWRAAQ Digital to launch a cutting-edge Block Trade Negotiation System, according to a press release. The newly integrated platform enables institutional and high-net-worth investors to negotiate large-scale transactions securely within private digital negotiation rooms, minimizing market impact and optimizing execution quality. The strategic partnership underscores Alkhabeer Capital's ongoing digital transformation journey and its commitment to enhancing execution efficiency, confidentiality, and compliance in block trade transactions. The CEO of Alkhabeer Capital, Ahmad Saud Ghouth, said: 'Our partnership with AWRAAQ Digital reflects our vision for innovation and digital transformation.' Ghouth added: 'This system represents a qualitative leap in the execution quality of block trade negotiations and reinforces our position as a leading provider of advanced trading solutions.' Meanwhile, Khalid Alruwaili, the CEO of AWRAAQ Digital, said: 'We are proud to align our platform with Alkhabeer Capital's systems, paving the way for a unique technical solution that enhances the efficiency of block trades and supports the development of Saudi Arabia's financial market.' This initiative marks a significant advancement in Alkhabeer Capital's digital roadmap and reflects its commitment to delivering advanced trading experiences in line with the highest regulatory and confidentiality standards. Alkhabeer Capital offers investment products and solutions in private equity, financial markets, and real estate investments, in addition to offering investment banking and brokerage services. Earlier in 2025, Alkhabeer Capital entered into a strategic partnership agreement with Fasanara Capital, a $5 billion global asset manager specializing in technology-enabled credit solutions.
Zawya
an hour ago
- Zawya
Burjeel Holdings reports 129% increase Q2'25 net profit, with accelerated revenue growth
Abu Dhabi, United Arab Emirates: Burjeel Holdings PLC ('Burjeel' or 'the Group'), a leading super-specialty healthcare services provider in MENA listed on the Abu Dhabi Securities Exchange (SYMBOL: BURJEEL; ISIN: AEE01119B224), today announced its financial results in accordance with International Financial Reporting Standards (IFRS) for the three-month and six-month periods ended 30 June 2025. Executing with Focus: Specialized Services, Efficiency, and Expansion Burjeel Holdings accelerated its strategic execution in Q2 2025 with a series of high-impact initiatives that deepened specialization and broadened patient access. The Group expanded its advanced oncology network, integrating Dubai's Advanced Care Oncology Center and opening new Burjeel Cancer Institute (BCI) clinics in Al Ain, Sharjah, and Oman, reinforcing its position as a regional leader in complex cancer care. The UAE's first dedicated cancer pharmacy was also inaugurated, strengthening oncology support infrastructure. In parallel, Burjeel launched a regional mental health platform through its joint venture Alkalma, opening four specialist mental health centers across the UAE and Saudi Arabia. This marked the first phase of a multi-year expansion strategy aimed at addressing rising demand for mental wellness services. In Saudi Arabia, the Group acquired a major physiotherapy facility in Riyadh under the PhysioTherabia platform, adding scale and unlocking turnaround potential through secured government contracts. Investments in operational resilience and access continued with the AED 170 million acquisition of the Medeor Hospital Dubai building, converting long-term lease obligations into ownership and enhancing cost structure flexibility. The Group also expanded its primary care footprint with a new medical center launched on Saadiyat Island, aligning with its growth strategy in high-yield urban catchments. In medical innovation, Burjeel launched DOCKTOUR, a transformative healthcare logistics joint venture with AD Ports Group, aiming to redefine how medical services and infrastructure are delivered to underserved and remote communities. Several specialized centers were introduced, including the region's first Al Muderis Osseointegration Clinic for advanced limb reconstruction, a state-of-the-art Epilepsy Monitoring Unit, and expanded capabilities in rare diseases, hematology, and metabolic research. Additionally, the Group continued its digital transformation with AI-powered diagnostics and led groundbreaking research in microgravity, aiming to transform care for patients with diabetes in space and on Earth. John Sunil, Chief Executive Officer of Burjeel Holdings, said: 'The second quarter delivered exceptionally strong results, with 19% revenue growth driven by a 12% increase in patient footfall and improved yield. EBITDA rose by 59%, accompanied by a margin uplift to 22%. This robust performance significantly strengthened the first-half outcome, underscoring Burjeel Holdings' resilience and long-term sustainable growth. 'These results reflect tangible progress in key operational areas such as physician manpower optimization, formulary management, and cost control, while our strategic focus on super-specialty care is beginning to yield measurable benefits, enhancing both revenue and profitability. We continue to invest in high-value services and next-generation care facilities to support long-term momentum. 'We also advanced key strategic priorities, reinforcing leadership in complex care across oncology, transplants, fertility, mental health, and diagnostics. Our oncology platform is now the UAE's largest private network, featuring new cancer clinics and cell and gene therapy capabilities. The Alkalma mental health platform is scaling regionally, alongside rehabilitation services through over 30 PhysioTherabia centers in Saudi Arabia. Additionally, we introduced the region's first Osseointegration Clinic for cutting-edge prosthetic care. 'In parallel with expanding our network of primary care and medical centers, we deepened partnerships with government and corporate stakeholders and accelerated digital integration through Oracle Health EMR and AI-powered tools. Building on this platform, we entered into pivotal partnerships in oncology, value-based care, diagnostics, and international healthcare innovation, establishing the Group as the healthcare partner of choice. 'Burjeel Holdings is uniquely positioned to capture significant opportunities across the region, supported by rising demand for complex care and a growing population. Our focus remains on converting recent investments into sustained expansion and margin improvement, while maintaining disciplined financial management to support long-term shareholder value. Net profit growth of 129% in the reporting quarter reinforces this trajectory and strengthens the foundation for consistent shareholder returns.' Q2'25: Growth Delivered, Efficiency Embedded Burjeel Holdings delivered strong top-line growth of 18.7% to AED 1,403 million in Q2'25, driven by a 12.1% increase in patient footfall, higher patient yield, and the continued ramp-up of newly launched facilities across the network. Revenue in H1'25 rose 12.2% to AED 2,677 million, with total patient visits reaching 3.4 million. Oncology remained a core growth driver, with revenue rising 36.7% in Q2'25 and 38.1% in H1'25, underpinned by oncology network expansion and improved conversion in surgical and advanced therapies. Other specialties also recorded solid gains in H1'25, including urology (+18%), emergency medicine (+17%), cardiology (+16%), and gastroenterology (+13%). Inpatient footfall rose 17.7% in Q2'25, reflecting strong demand across key specialties and a ramp-up in elective surgeries post-Ramadan. The Group performed 22,930 surgeries, up 18.7%, with momentum concentrated at Burjeel Medical City, Burjeel Specialty Hospital Sharjah, Lifecare Hospital Musaffah and Burjeel Royal Hospital Al Ain. Bed occupancy improved to 69%, up from 65% a year ago, and averaged 69% in H1'25. Inpatient volumes rose 14.6% over the first half. Outpatient footfall grew 12.0% in Q2'25, accelerating from 5.2% in Q1, driven by primary care and physiotherapy centers, along with robust demand in oncology, pediatrics, ophthalmology, and family medicine. Utilization improved to 68%, up from 65% in Q1'25, enabled by optimized hiring and scaling of clinical teams. Leading facilities included Burjeel Medical City, Lifecare Hospital Baniyas, and Burjeel Day Surgery Center Barari. In H1'25, outpatient volumes increased 8.6%. EBITDA rose 59.4% to AED 306 million in Q2'25, fueled by strong revenue growth, enhanced physician productivity, and better performance across recently ramped-up assets. This includes AED 72 million in gains from lease liability derecognition following the Dubai Medeor Hospital acquisition. The EBITDA margin expanded 5.6 p.p. to 21.8%. In H1'25, EBITDA increased 14.2% to AED 487 million, with a margin of 18.2%. Net profit surged 128.9% to AED 148 million in Q2'25, reflecting margin expansion, enhanced operating leverage, and asset optimization. In H1'25, net profit rose 10.6% to AED 187 million. Hospitals Lead Growth, Medical Centers Accelerate The Hospitals segment continued to drive Group performance, contributing 89% of total revenue in Q2'25. Revenue grew 17.3% to AED 1,245 million, supported by strong growth in patient volumes and sustained demand for complex care services. Segment EBITDA rose by 40.6%, led by strong performance across key hospitals, including Burjeel Medical City, Burjeel Hospital Abu Dhabi, Burjeel Day Surgery Center Barari and Burjeel Royal Hospital Al Ain. The Medical Centers segment also delivered exceptional growth, with Q2'25 revenue rising 36.8% to AED 121 million. This was driven by the successful ramp-up of over 45 new centers across the UAE and Saudi Arabia, expanding access to high-quality outpatient and physiotherapy services. In H1'25, Medical Centers revenue increased 26.7% to AED 229 million, reflecting the Group's strong momentum in scaling primary care. BMC: Scaling Patient Base & Driving Efficiency Gains Burjeel Medical City (BMC), the Group's flagship facility, remained a key growth engine, achieved 14.7% growth in revenue to AED 333 million, driven by a 30.4% increase in patient volumes. This performance was underpinned by a higher outpatient share, strong oncology momentum, and robust post-Ramadan demand for minimally invasive and elective procedures. Bed occupancy improved to 68%, underscoring stronger inpatient utilization. Revenue from BMC in H1'25 increased 13.0% to AED 648 million. BMC EBITDA rose 21.3% to AED 59 million in Q2'25, with the EBITDA margin improving to 17.6%. In H1'25, EBITDA grew 20.8% YoY to AED 112 million, with margin expansion of 1.1 p.p. to 17.3%. Profitability growth was supported by scale efficiencies and continued investment in super-specialty services. BMC's performance reinforces its strategic role as the Group's key platform for complex care and future value creation. Disciplined Leverage with Strong Cash Generation Operating cash flow increased 8.1% YoY in H1'25, driven by improved operational performance and disciplined working capital management. Maintenance CAPEX remained in line with guidance, while Growth CAPEX totaled AED 403 million, driven by strategic M&A activities and ongoing network expansion. Free cash flow (FCF)1 conversion improved to 54% in H1'25. The Group's net debt / pre-IFRS 16 LTM EBITDA2 stood at 1.8x as of 30 June 2025, reflecting the acquisition of the Dubai hospital building. This strategic transaction enhanced asset ownership while optimizing the Group's cost structure. The Group maintains a strong and flexible balance sheet, enabling continued investment in growth opportunities. With no contingent off-balance sheet liabilities, management remains focused on optimizing capital structure through debt reduction, refinancing, and tenure extension. Dividend Policy Burjeel Holdings is committed to delivering value to stakeholders while ensuring alignment with strategic growth plans. The Group maintains a dividend policy with a payout range of 40–70% of net income, depending on investment needs for expansion. In May 2025, the Group declared a full-year dividend of AED 170 million for FY2024, representing 47% of net profit. This reflects strong profitability and a balanced approach to rewarding shareholders while supporting long-term growth. About Burjeel Holdings Founded in 2007, Burjeel Holdings is a leading super-specialty healthcare services provider in the UAE and Oman, and it operates a growing specialized healthcare segment in Saudi Arabia. The Group operates an integrated and multi-brand healthcare ecosystem across primary, secondary, tertiary, and quaternary medical care, ensuring complex care delivery to patients across all socioeconomic groups. Its network comprises 112 assets across the UAE, Oman, and Saudi Arabia, including 20 hospitals, 37 medical centers, 30 physiotherapy and wellness centers, 15 pharmacies, and 10 other allied services. Burjeel Holdings' brands include Burjeel, Medeor, LLH, Lifecare, PhysioTherabia, Alkalma, and Tajmeel.
Zawya
2 hours ago
- Zawya
Spinneys continues positive momentum with first-half revenue of AED 1.8bln
H1 2025 revenue increased 13.7% to AED 1.8 billion, driven by like-for-like sales growth, new store openings, increase in Online sales and higher penetration of Fresh and Private Label sales Adjusted EBITDA of AED 365 million, up 20.0%, at an industry-leading margin of 20.1% Profit before tax grew 24.4% to AED 202 million, with profit for the period up 16.2% to AED 170 million 9 new stores opened across the UAE and Saudi Arabia over the last 12 months, with 10-12 new stores planned for the UAE and Saudi Arabia through 2025, strengthening Spinneys' presence in core markets Board approves interim dividend of AED c.120 million, or 3.32 fils per share for H1 2025 Dubai, UAE: Spinneys ('Spinneys' or the 'Company'), the region's leading premium fresh food retailer, has announced its financial results for the three-month and six-month period ended 30 June 2025. First-half revenues reached AED 1.8 billion, increasing 13.7% vs. H1 2024, driven by six new store openings during the first half, increased Fresh and Private Label sales, strong like-for-like growth, and higher Online penetration. Profit before tax grew by 24.4% to AED 202 million, with profit for the period increasing by a strong 16.2% to AED 170 million, after absorbing the impact of 6% additional tax on applicability of Pillar Two Rules which provides for a minimum tax of 15%, thus, reflecting Spinneys' industry-leading efficiency and margin profile. Sunil Kumar, Chief Executive Officer at Spinneys, commented: ' Our strong performance in the first half of 2025 reflects the strength of the Spinneys brand and our continued focus on delivering fresh, high-quality food experiences to our customers across the region. Strong like-for-like growth, the success of our Fresh and Private Label ranges, and the acceleration of our online and store expansion strategy have all contributed to robust top- and bottom-line results. We were especially encouraged by the successful launch of Discovery by Spinneys, our new premium private label range, which has already resonated strongly with customers. This marks the beginning of a broader journey to bring exclusive, high-quality products to our customers.' 'What truly sets Spinneys apart is the strong culture we've built — one rooted in ownership, service, and teamwork. Our people are the heartbeat of our business, and their commitment to excellence continues to drive our growth and resilience. As we look ahead, we remain focused on deepening our presence in core markets, continuing our expansion in Saudi Arabia, enhancing operational efficiencies, and creating long-term value for our stakeholders.' Financial Highlights AED (m) Q2 2025 Q2 2024 YoY Growth (%) H1 2025 H1 2024 YoY Growth (%) Revenue 910 783 16.2% 1,816 1,598 13.7% Gross Profit 378 323 16.9% 753 659 14.2% Adj. EBITDA 183 153 19.3% 365 304 20.0% Profit Before Tax 100 80 25.7% 202 163 24.4% Profit 85 72 18.5% 170 146 16.2% Record Top-Line Growth with Best-in-Class Profitability Revenue: Increased by 13.7% year-on-year, reaching AED 1.8 billion in the first six months of 2025. Top-line growth was driven by like-for-like sales growth of 12.1% and the opening of nine new stores across the UAE and Saudi Arabia since July 2024, and particularly strong performance in Fresh (64.3%) and Private Label sales (44.7%), with penetration growing by 0.5% and 1.9%, respectively. Online sales penetration grew to 16.2% during the year, as compared to 13.6% in H1 2024. Profitability: Gross profit increased by 14.2% year-on-year to AED 753 million in the six months ended 30 June 2025, with a stable gross profit margin of 41.5% compared to 41.3% in 2024, achieved through efficient sourcing and supply chain management and Spinneys' highly successful Private Label strategy, which emphasizes high-margin products. Adjusted EBITDA totaled AED 365 million in the first half of 2025, up 20.0% year-on-year, with an adjusted EBITDA margin of 20.1%, compared to 19.0% in 2024. Profit before tax grew by 24.4% to AED 202 million in the first half of 2025 at an 11.1% profit before tax margin (up from 10.2% in H1 2024), while profit for the period increased by 16.2% to AED 170 million at a 9.4% profit margin (up from 9.2% in H1 2024). Transaction growth: Transaction volume grew by 12.2% year-on-year to 20.6 million in the first half of 2025, reflecting growing customer demand on the back of supportive macroeconomic dynamics, while the average basket size remained flat at AED 88. Continued Strategic Execution Store network expansion: Spinneys continued to successfully execute its growth strategy through the expansion of its store footprint. From 1 July 2024 to 30 June 2025 the Company opened 8 new stores in the UAE and one in Saudi Arabia, resulting in a significant increase in gross selling area. In post period events, Spinneys opened two further stores in the UAE namely, Spinneys Mina Port and The Kitchen by Spinneys Wafi Mall. Aligned with global retail shifts: Spinneys continues to embed key consumer and operational trends into its growth strategy — including preventative wellness, in-store innovation, and employee empowerment. These themes were reinforced during the recent Consumer Goods Forum in Amsterdam, where CEO Sunil Kumar shared insights on the evolving Middle Eastern retail landscape, further positioning Spinneys as a regional thought leader. New Premium Private Label: Spinneys recently launched Discovery by Spinneys, a new premium private label range aimed at elevating perceptions of private label quality. The line offers curated, globally sourced products, starting with an exclusive Scottish strawberry variety that broke category sales records and earned praise for its standout flavour. The launch reflects strong demand for differentiated offerings, with further category expansions planned through 2025. Business Outlook Management reaffirms its previously communicated guidance for full-year 2025 and maintains a positive outlook for 2025, expecting to open 10-12 new stores across the UAE and Saudi Arabia for the full year. Annual revenue growth is expected to be between 9-11%, driven by new store openings coupled with like-for-like sales growth of 4-6%. The Company expects to maintain its industry-leading adjusted EBITDA margin of 19-20%. About Spinneys Spinneys' story started in 1961 when the first grocery opened in Al Nasr Square, Dubai. It has since grown to become the leading premium fresh food retailer in the region, with 83 stores (71 owned and 12 operated, including Waitrose) across the UAE, Oman and Saudi Arabia. Much loved by expats and locals in the region, Spinneys enjoys a well-deserved reputation for forward thinking, keeping pace with changes in cooking trends and the emergence of new products worldwide. Today, Spinneys has built a name for supplying top-quality produce and offering an elevated level of customer service. Food quality, safety and freshness have always been at the forefront of the Company's ethos – just one reason the Spinneys brand is defined as 'The fresher experience'.
